Pairing collectivity in medium-mass neutron-rich nuclei near drip-line

We look for collective excitations originating from the strong surface pairing in unstable nuclei near the neutron drip-line. The soft dipole excitation is such a pairing mode as it exhibits a character of core-vs-dineutron motion. Possibility of the hydrodynamic phonon mode (the Anderson-Bogoliubov mode) is also discussed.Comment: 9 pages, a talk presented at Collective Motion in Nuclei under Extreme Conditions (COMEX2), June 20-23, 2006, St. Goar, German

A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis

Products of ultraviolet (UV) irradiation such as reactive oxygen species (ROS) and nitric oxide (NO) stimulate melanin synthesis. Reactive sulfur species (RSS) have been shown to have strong ROS and NO scavenging effects. However, the instability and low retention of RSS limit their use as inhibitors of melanin synthesis. The free thiol at Cys34 on human serum albumin (HSA) is highly stable, has a long retention and possess a high reactivity for RSS. We report herein on the developm ent of an HSA based RSS delivery system. Sulfane sulfur derivatives released from sodium polysulfides (Na 2 S n ) react readily with HSA. An assay for estimating the elimination of sulfide from polysulfide showed that almost all of the sulfur released from Na 2 S n bound to HSA. The Na 2 S n -treated HSA was found to efficiently scavenge ROS and NO produced from chemical reagents. The Na 2 S n -treated HSA was also found to inhibit melanin synthesis in B16 melanoma cells and this inhibition was independent of the number of added sulfur atoms. In B16 melanoma cells, the Na 2 S n -treated HSA also inhibited the levels of ROS and NO induced by UV radiation. Finally, the Na 2 S n -treated HSA inhibited melanin synthesis from L-DOPA and mushroom tyrosinase and suppressed the extent of aggregation of melanin pigments. These data suggest that Na 2 S n -treated HSA inhibits tyrosinase activity for melanin synthesis via two pathways; by directly inhibiting ROS signaling and by scavenging NO. These findings indicate that Na 2 S n -treated HSA has potential to be an attractive and effective candidate for use as a skin whitening agent

A toy model of open membrane field theory in constant 3-form flux

Based on an explicit computation of the scattering amplitude of four open membranes in a constant 3-form background, we construct a toy model of the field theory for open membranes in the large C field limit. It is a generalization of the noncommutative field theories which describe open strings in a constant 2-form flux. The noncommutativity due to the B-field background is now replaced by a nonassociative triplet product. The triplet product satisfies the consistency conditions of lattice 3d gravity, which is inherent in the world-volume theory of open membranes. We show the UV/IR mixing of the toy model by computing some Feynman diagrams. Inclusion of the internal degree of freedom is also possible through the idea of the cubic matrix.Comment: 31 pages, latex, 2 eps figure

Pairing competition in a quasi-one-dimensional model of organic superconductors (TMTSF)2X_{2}X in magnetic field

We microscopically study the effect of the magnetic field (Zeeman splitting) on the superconducting state in a model for quasi-one-dimensional organic superconductors (TMTSF)$_{2}X$. We investigate the competition between spin singlet and spin triplet pairings and the Fulde-Ferrell-Larkin-Ovchinnikov(FFLO) state by random phase approximation. While we studied the competition by comparison with the eigenvalue of the gap equation at a fixed temperature in our previous study (Phys. Rev. Lett. \textbf{102} (2009) 016403), here we obtain both the $T_c$ for each pairing state and a phase diagram in the $T$(temperature)-$h_z$(field)-$V_y$(strength of the charge fluctuation) space. The phase diagram shows that consecutive transitions from singlet pairing to the FFLO state and further to $S_z=1$ triplet pairing can occur upon increasing the magnetic field when $2k_{F}$ charge fluctuations coexist with $2k_{F}$ spin fluctuations. In the FFLO state, the singlet d-wave and $S_{z}=0$ triplet $f$-wave components are strongly mixed especially when the charge fluctuations are strong.Comment: 11 pages, 9 figure

Fulde-Ferrell-Larkin-Ovchinnikov State in Heavy Fermion Superconductors

The Fulde-Ferrell-Larkin-Ovchinnikov (FFLO) state is a novel superconducting state in a strong magnetic field characterized by the formation of Cooper pairs with nonzero total momentum (k \uparrow, -k+q \downarrow), instead of the ordinary BCS pairs (k \uparrow, -k \downarrow). A fascinating aspect of the FFLO state is that it exhibits inhomogeneous superconducting phases with a spatially oscillating order parameter and spin polarization. The FFLO state has been of interest in various research fields, not only in superconductors in solid state physics, but also in neutral Fermion superfluid of ultracold atomic gases and in color superconductivity in high energy physics. In spite of extensive studies of various superconductors, there has been no undisputed experimental verification of the FFLO state, mainly because of the very stringent conditions required of the superconducting materials. Among several classes of materials, certain heavy fermion and organic superconductors are believed to provide conditions that are favorable to the formation of the FFLO state. This review presents recent experimental and theoretical developments of the FFLO state mainly in heavy fermion superconductors. In particular we address the recently discovered quasi-two-dimensional superconductor CeCoIn_5, which is a strong candidate for the formation of the FFLO state.Comment: 17 pages, 12 figures with jpsf2.cls, to be published in J. Phys. Soc. Jpn. (Special Topics - Frontiers of Novel Superconductivity in Heavy Fermion Compounds

Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models

<p>Abstract</p> <p>Background</p> <p>The binding of EGFR and its ligands leads to autophosphorylation of receptor tyrosine kinase as well as subsequent activation of signal transduction pathways that are involved in regulating cellular proliferation, differentiation, and survival. An EGFR inhibitor, cetuximab binds to EGFR and consequently blocks a variety of cellular processes. <it>KRAS</it>/<it>BRAF </it>mutations are known to be associated with a low response rate to cetuximab. In the present study, to clarify the anti-tumor mechanisms of cetuximab, we evaluated the <it>KRAS</it>/<it>BRAF </it>status, phosphorylation level of the EGFR pathway, and the tumor suppression effect in vivo, using a human colon cancer cell line HT29, which exhibited the highest EGFR expression in response to the cetuximab therapy among the 6 colorectal cancer cell lines tested.</p> <p>Findings</p> <p>The conventional growth suppression assay did not work efficiently with cetuximab. EGF, TGF-α, and IGF activated the EGFR/MAPK cell signaling pathway by initiating the phosphorylation of EGFR. Cetuximab partially inhibited the EGFR/MAPK pathway induced by EGF, TGF-α, and IGF. However, cetuximab exposure induced the EGFR, MEK, and ERK1/2 phosphorylation by itself. Mouse xenograft tumor growth was significantly inhibited by cetuximab and both cetuximab-treated and -untreated xenograft specimens exhibited phosphorylations of the EGFR pathway proteins.</p> <p>Conclusions</p> <p>We have confirmed that cetuximab inhibited the EGFR/MAPK pathway and reduced tumor growth in the xenografts while the remaining tumor showed EGFR pathway activation. These results suggest that: ( i ) The effect of cetuximab in growth signaling is not sufficient to induce complete growth suppression in vitro; ( ii ) time-course monitoring may be necessary to evaluate the effect of cetuximab because EGFR signaling is transmitted in a minute order; and ( iii ) cetuximab treatment may have cells acquired resistant selectively survived in the heterogeneous cancer population.</p

GWAS of bipolar disorder

Genome-wide association studies (GWASs) have identified several susceptibility loci for bipolar disorder (BD) and shown that the genetic architecture of BD can be explained by polygenicity, with numerous variants contributing to BD. In the present GWAS (Phase I/II), which included 2964 BD and 61 887 control subjects from the Japanese population, we detected a novel susceptibility locus at 11q12.2 (rs28456, P=6.4 × 10−9), a region known to contain regulatory genes for plasma lipid levels (FADS1/2/3). A subsequent meta-analysis of Phase I/II and the Psychiatric GWAS Consortium for BD (PGC-BD) identified another novel BD gene, NFIX (P best=5.8 × 10−10), and supported three regions previously implicated in BD susceptibility: MAD1L1 (P best=1.9 × 10−9), TRANK1 (P best=2.1 × 10−9) and ODZ4 (P best=3.3 × 10−9). Polygenicity of BD within Japanese and trans-European-Japanese populations was assessed with risk profile score analysis. We detected higher scores in BD cases both within (Phase I/II) and across populations (Phase I/II and PGC-BD). These were defined by (1) Phase II as discovery and Phase I as target, or vice versa (for ‘within Japanese comparisons’, Pbest~10−29, R2~2%), and (2) European PGC-BD as discovery and Japanese BD (Phase I/II) as target (for ‘trans-European-Japanese comparison,’ Pbest~10−13, R2~0.27%). This ‘trans population’ effect was supported by estimation of the genetic correlation using the effect size based on each population (liability estimates~0.7). These results indicate that (1) two novel and three previously implicated loci are significantly associated with BD and that (2) BD ‘risk’ effect are shared between Japanese and European populations

The Physics of the B Factories

This work is on the Physics of the B Factories. Part A of this book contains a brief description of the SLAC and KEK B Factories as well as their detectors, BaBar and Belle, and data taking related issues. Part B discusses tools and methods used by the experiments in order to obtain results. The results themselves can be found in Part C

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

S